Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $91.8750 (-2.34%) ($90.3200 - $95.4600) on Fri. Sep. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.4% (three month average) | RSI | 25 | Latest Price | $91.8750(-2.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2.1% a day on average for past five trading days. | Weekly Trend | LGND declines -3.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(49%) IWM(48%) IWC(47%) | Factors Impacting LGND price | LGND will decline at least -1.2% in a week (0% probabilities). VIXM(-21%) UUP(-16%) VXX(-14%) IGOV(-7%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.2% (StdDev 2.4%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $88.53(-3.64%) | Resistance Level | $100.83 | 5 Day Moving Average | $95.11(-3.4%) | 10 Day Moving Average | $97.5(-5.77%) | 20 Day Moving Average | $100.83(-8.88%) | To recent high | -27.5% | To recent low | 0% | Market Cap | $1.477b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |